Third View Private Wealth’s Veracyte VCYT Stock Holding History

Third View Private Wealth’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,583	Closed	-$235K	–	294
2025 Q4	$235K	Buy	+5,583	New	+$225K	0.03%	251

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Third View Private Wealth's VCYT Position: Q1 2026 in Review

Third View Private Wealth sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 5,583 shares — an estimated $235K sold.

Third View Private Wealth first reported a position in VCYT in Q4 2025 and held it in 1 quarter. The position peaked at $235K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Third View Private Wealth reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
Third View Private Wealth sold 5,583 Veracyte shares in Q1 2026, an estimated $235K.
Third View Private Wealth first reported a position in Veracyte in Q4 2025 and held it in 1 quarter.
Third View Private Wealth's Veracyte position peaked at $235K in Q4 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Third View Private Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.